Journals / Bilecik Şeyh Edebali Üniversitesi Sağlık Bilimleri Fakültesi Dergisi / 2023 / Cilt: 1 Sayı: 2

Losartan or Nebivolol ? Which One Is More Effective in Erectile Dysfunction ?

Losartan Mı Nebivolol Mu ? Hangisi Erektil Disfonksiyonda Daha Etkin ?

Pages
119–127
Publication Date
2023-09-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, as can be seen from the studies conducted in comparison with losartan, the clinical improvement of losartan is seen to be superior.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To protect hypertensive patients against ED (erectile dysfunction) and to provide better clinical improvement in terms of sexual health and to evaluate the positive effects of these drugs on ED, it is aimed to compare the drugs containing previously known nebivolol and unknown losartan that can be recommended to these patients.
📊
Key Findings & Data:Two separate forms will be filled out for diabetic sexually active male patients over the age of 18.
💡
Conclusion & Impact:However, as can be seen from the studies conducted in comparison with losartan, the clinical improvement of losartan is seen to be superior.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Losartan · Nebivolol · Hipertansiyon

Abstract

To protect hypertensive patients against ED (erectile dysfunction) and to provide better clinical improvement in terms of sexual health and to evaluate the positive effects of these drugs on ED, it is aimed to compare the drugs containing previously known nebivolol and unknown losartan that can be recommended to these patients. Two separate forms will be filled out for diabetic sexually active male patients over the age of 18. Patients will be in 3 groups: those who use losartan, those who use nebivolol, and the control group who do not use these drugs. A total of 85 patients were enrolled in the study. According to the male sexual health assessment form, the losartan and nebivolol group are statistically significant compared to the control group (p<0.0001). According to the international erectile function form, losartan and nebivolol group were also found to be statistically significant compared to the control group (p<0.0001). Nebivolol shows its positive effect on ED by vasodilation by ensuring the release of NO from the vascular endothelium. However, as can be seen from the studies conducted in comparison with losartan, the clinical improvement of losartan is seen to be superior.

Özet

Hipertansif hastaları ED (erektil disfonksiyon) karşı korumak ve cinsel sağlık açısından daha iyi klinik düzelme sağlamak ve bu ilaçların ED üzerine olumlu etkilerini değerlendirmek için bu hastalara önerilebilecek daha önce bilinen nebivolol ve çok bilinmeyen losartan içerikli ilaçları karşılaştırmak amaçlanmıştır. 18 yaş üstü diyabetik cinsel aktif erkek hastalara iki ayrı form doldurulacak. Hastalar losartan kullananlar, nebivolol kullananlar ve bu ilaçları kullanmayan kontrol grubu olmak üzere 3 grup olacaktır. Toplam 85 hasta çalışmaya alınmıştır. Erkek cinsel sağlık değerlendirme formuna göre losartan ve nebivolol grubu kontrol grubuna göre anlamlıdır (p<0,0001). Uluslararası erektil işlev formuna göre de losartan ve nebivolol grubu da kontrol grubuna göre istatistiksel olarak anlamlı bulunmuştur (p<0,0001). Nebivolol ED üzerindeki olumlu etkisini damar endotelinden NO salınımını sağlayarak vazodilatasyon yaparak gösterir. Ancak losartan ile kıyaslandığında yapılan çalışmalarda görüldüğü gibi losartan klinik düzelme daha üstün görülmektedir.

🔖

Cite This Article

YILMAZ, A. H., KAPLANGORAY, M., DEVECİ, E. (2023). Losartan or Nebivolol ? Which One Is More Effective in Erectile Dysfunction ?. Bilecik Şeyh Edebali Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, Cilt: 1 Sayı: 2, 119–127. https://ajindex.com/articles/976472

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Andersson, K. E., & Wagner, G. (1995). Physiology of penile erection. Physiological Reviews, 76, 191. https://doi.org/10.1152/physrev.1995.75.1.191
  2. Ardahanlı, İ., & Çelik, M. (2020). Can myocardial performance index predict early cardiac risks in erectile dysfunction?. The Aging Male, 23(5), 1355-1361. https://doi.org/10.1080/13685538.2020.1768367
  3. Aytac, I. A., McKinlay, J. B., & Krane R. J. (1999). The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU International, 84(1), 50-56. https://doi.org/10.1046/j.1464-410x.1999.00142.x
  4. Bearelly, P., Moore, S. A., Avellino, G., Ko, D. S. C. (2023). Diabetes and Erectile Dysfunction. In: Johnstone, M., Veves, A. (eds) Diabetes and Cardiovascular Disease. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-031-13177-6_20
  5. Bortel, L. M. V., Bulpitt, C. J., & Fici, F. (2005). Quality of life and antihypertensive effect with nebivolol and losartan. American journal of hypertension, 18(8), 1060-1066. https://doi.org/10.1016/j.amjhyper.2005.03.733
  6. Boydak, B., Nalbantgil, S., Fici, F., Nalbantgil, I., Zoghi, M., Ozerkan, F.,. & Onder, R. (2005). A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clinical drug investigation, 25, 409-416. https://doi.org/10.2165/00044011-200525060-00006
  7. Brixius, K., Middeke, M., Lichtenthal, A., Jahn, E., & Schwinger, R. H. (2007). N itric o xide, e rectile d ysfunction and beta‐blocker treatment (mr noed study): benefit of nebivolol versus metoprolol in hypertensive men. Clinical and Experimental pharmacology and physiology, 34(4), 327-331. https://doi.org/10.1111/j.1440-1681.2007.04551.x
  8. Caro, J. L. L., Vidal, J. V. L., Roca, M. A., Bravo, C. P., Vicente, J. A., Ferrario, C. M., & Zamorano, M. A. S. (2001). Sexual dysfunction in hypertensive patients treated with losartan. The American journal of the medical sciences, 321(5), 336-341. https://doi.org/10.1097/00000441-200105000-00006
  9. Chen, Y., Li, S. X., Yao, L. S., Wang, R., & Dai, Y. T. (2007). Valsartan treatment reverses erectile dysfunction in diabetic rats. International Journal Of Impotence Research, 19(4), 366-370. https://doi.org/10.1038/sj.ijir.3901534
  10. Chiu, A. T., McCall, D. E., Price Jr, W. A., Wong, P. C., Carini, D. J., Duncia, J. V.,. & Timmermans, P. B. (1991). In vitro pharmacology of DuP 753. American Journal of Hypertension, 4(4_Pt_2), 282S-287S.